Form 4: Doximity Director Sells Shares After Option Exercise
Insider Transaction Report
Doximity Director Regina Benjamin exercised stock options and subsequently sold 5,000 Class A common shares for $70.5 each under a pre-arranged trading plan.
Summary
- Regina M. Benjamin, a Director of Doximity, Inc. (DOCS), reported changes in her beneficial ownership of company securities.
- On September 12, 2025, Benjamin exercised 5,000 stock options with an exercise price of $2.21 per share, converting them into 5,000 shares of Class B Common Stock.
- Immediately following the option exercise, the 5,000 shares of Class B Common Stock were converted into 5,000 shares of Class A Common Stock.
- On the same date, September 12, 2025, Benjamin sold 5,000 shares of Class A Common Stock at a price of $70.5 per share.
- These sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Benjamin on February 26, 2025.
- Following these transactions, Benjamin beneficially owns 19,839 shares of Class A Common Stock and 356,138 stock options (right to buy).
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction involving option exercise and subsequent sale under a pre-arranged 10b5-1 trading plan, which is generally neutral in sentiment as it does not reflect new discretionary decisions based on recent material non-public information.
Positives
- The exercise of stock options indicates that the options were in-the-money, reflecting a positive valuation for the underlying shares relative to the exercise price of $2.21.
- The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, which demonstrates a structured approach to insider stock transactions and helps mitigate concerns about opportunistic selling.
Negatives
- The sale of 5,000 Class A Common Stock by a director, even if pre-planned, represents a reduction in insider ownership.
Risks
- No specific risks were mentioned in this Form 4 filing beyond the inherent market risks associated with holding equity securities.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing reports a routine insider transaction for Doximity, Inc. and does not provide information directly related to broader industry trends or competitive landscape.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Administrative Power of Attorney | Regina Benjamin granted a Limited Power of Attorney to Anna Bryson and John Vaughan to execute and file SEC forms (Form ID, 3, 4, 5, Schedules 13D/G) on her behalf. This is a standard administrative arrangement to facilitate timely SEC filings. | 09/03/2025 | This administrative change streamlines the process for filing required SEC documents for the director and does not indicate any substantive change in corporate governance policies or procedures. |
Stakeholder Impact
- Shareholders: The sale of shares by a director, even if pre-planned, slightly dilutes the insider ownership percentage. However, the transaction is routine and unlikely to significantly impact shareholder sentiment.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- The remaining 356,138 stock options held by Regina Benjamin will continue to be subject to their vesting schedule and expiration terms.
Key Dates
| Date | Description |
|---|---|
| 09/02/2020 | Grant date of the stock option, which vested in 36 equal monthly installments thereafter. |
| 02/26/2025 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 09/03/2025 | Date the Limited Power of Attorney was executed by Regina Benjamin. |
| 09/12/2025 | Date of stock option exercise, conversion of Class B to Class A, and sale of Class A Common Stock. |
| 09/16/2025 | Date the Form 4 was signed and filed. |
| 09/01/2030 | Expiration date of the exercised stock option. |
Recommendation
holdThe filing details a pre-scheduled insider transaction (option exercise and sale) under a Rule 10b5-1 plan. Such routine sales by directors, especially when planned in advance, do not typically indicate a change in the company's fundamental outlook or warrant a strong buy/sell recommendation. Investors should consider broader company performance and market conditions rather than this isolated, pre-planned transaction.
Keywords
Doximity, DOCS, Insider Trading, Form 4, Stock Option Exercise, Share Sale, Regina Benjamin, 10b5-1 Plan, Class A Common Stock, Class B Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.